September 7, 2006
Boston Scientific Confirms Increased Risk Linked to its Stent
Posted at September 7, 2006 2:19 PM in Defective Medical Devices
.
A leading stent manufacturer has admitted that there is an increased clot risk for those with Boston Scientific's cardiac stent. It is the first acknowledgment by a stent maker of an increased risk of the dangerous side effect of stents, which are small wire-mesh tubes used to keep previously clogged arteries open. Drug-coated stents, which are coated with medicine to prevent the growth of tissue after implantation, have sales exceeding $5 billion a year in a market dominated by Boston Scientific and Johnson & Johnson.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/332 .